300204 舒泰神
已收盘 10-13 15:00:00
资讯
新帖
简况
股市必读：舒泰神新发布《关于完成工商变更登记的公告》
证券之星 · 10-08
股市必读：舒泰神新发布《关于完成工商变更登记的公告》
舒泰神（300204）披露完成工商变更登记公告，9月30日股价上涨3.55%
证券之星 · 09-30
舒泰神（300204）披露完成工商变更登记公告，9月30日股价上涨3.55%
舒泰神（300204）9月24日主力资金净卖出2370.93万元
证券之星 · 09-28
舒泰神（300204）9月24日主力资金净卖出2370.93万元
9月21日舒泰神涨5.24%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 09-21
9月21日舒泰神涨5.24%，景顺长城医疗健康混合A基金重仓该股
舒泰神最新公告：子公司注射用波米泰酶α新增适应症临床试验申请获受理
证券之星 · 09-18
舒泰神最新公告：子公司注射用波米泰酶α新增适应症临床试验申请获受理
股市必读：舒泰神新发布《关于部分募集资金专户销户完成的公告》
证券之星 · 09-14
股市必读：舒泰神新发布《关于部分募集资金专户销户完成的公告》
舒泰神（300204）披露2026年第二次临时股东会决议公告，9月11日股价下跌2.19%
证券之星 · 09-11
舒泰神（300204）披露2026年第二次临时股东会决议公告，9月11日股价下跌2.19%
舒泰神：公司将于2026年9月10日召开2026年第二次临时股东会
证券日报网 · 09-07
舒泰神：公司将于2026年9月10日召开2026年第二次临时股东会
舒泰神：注射用波米泰酶α正积极推进全国挂网采购
证券之星 · 09-04
舒泰神：注射用波米泰酶α正积极推进全国挂网采购
舒泰神（300204）2026年中报简析：净利润同比下降49.25%
证券之星 · 08-26
舒泰神（300204）2026年中报简析：净利润同比下降49.25%
舒泰神(300204)6月30日股东户数6.4万户，较上期减少22.55%
证券之星 · 08-25
舒泰神(300204)6月30日股东户数6.4万户，较上期减少22.55%
图解舒泰神中报：第二季度单季净利润同比下降27.06%
证券之星 · 08-25
图解舒泰神中报：第二季度单季净利润同比下降27.06%
8月24日舒泰神跌5.32%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 08-24
8月24日舒泰神跌5.32%，景顺长城医疗健康混合A基金重仓该股
8月21日舒泰神跌7.89%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 08-21
8月21日舒泰神跌7.89%，景顺长城医疗健康混合A基金重仓该股
8月19日舒泰神跌5.49%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 08-19
8月19日舒泰神跌5.49%，景顺长城医疗健康混合A基金重仓该股
舒泰神（300204）披露子公司完成工商变更登记公告，8月17日股价下跌0.44%
证券之星 · 08-17
舒泰神（300204）披露子公司完成工商变更登记公告，8月17日股价下跌0.44%
舒泰神（300204）披露公司董事辞职公告，8月14日股价下跌3.06%
证券之星 · 08-14
舒泰神（300204）披露公司董事辞职公告，8月14日股价下跌3.06%
8月13日舒泰神涨7.90%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 08-13
8月13日舒泰神涨7.90%，景顺长城医疗健康混合A基金重仓该股
舒泰神：注射用波米泰酶α已获药品注册证书
证券之星 · 08-11
舒泰神：注射用波米泰酶α已获药品注册证书
舒泰神：积极推进博佳凝挂网采购、医保谈判及医院准入
证券之星 · 08-11
舒泰神：积极推进博佳凝挂网采购、医保谈判及医院准入
加载更多
公司概况
公司名称：
舒泰神(北京)生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2011-04-15
主营业务：
舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是苏肽生（注射用鼠神经生长因子）、特色品种舒泰清（复方聚乙二醇电解质散（IV））及其系列产品。
发行价格：
52.50
{"stockData":{"symbol":"300204","market":"SZ","secType":"STK","nameCN":"舒泰神","latestPrice":19.81,"timestamp":1791874983000,"preClose":20.51,"halted":0,"volume":11271839,"delay":0,"changeRate":-0.0341,"floatShares":454000000,"shares":541000000,"eps":-0.1661,"marketStatus":"已收盘","change":-0.7,"latestTime":"10-13 15:00:00","open":20.1,"high":20.22,"low":19.52,"amount":224000000,"amplitude":0.0341,"askPrice":19.82,"askSize":75,"bidPrice":19.81,"bidSize":665,"shortable":0,"etf":0,"ttmEps":-0.1661,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":5,"adr":0,"adjPreClose":20.51,"symbolType":"stock","openAndCloseTimeList":[[1791855000000,1791862200000],[1791867600000,1791874800000]],"highLimit":22.56,"lowLimit":18.46,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":541344345,"isCdr":false,"pbRate":13.76,"roa":"--","roe":"--","epsLYR":-0.16,"committee":0.178812,"marketValue":10724000000,"turnoverRate":0.0248,"status":1,"floatMarketCap":8987000000},"requestUrl":"/m/hq/s/300204","defaultTab":"news","newsList":[{"id":"2673010541","title":"股市必读：舒泰神新发布《关于完成工商变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673010541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673010541?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:52","pubTimestamp":1791402728,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，舒泰神报收于20.44元，上涨3.55%，换手率4.66%，成交量21.13万手，成交额4.34亿元。公司公告汇总：舒泰神已完成工商变更登记，注册资本变更为54134.4345万元，法定代表人、住所及经营范围同步更新。交易信息汇总资金流向9月30日主力资金净流出29.2万元，占总成交额0.07%；游资资金净流出585.16万元，占总成交额1.35%；散户资金净流入614.36万元，占总成交额1.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300204","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671783361","title":"舒泰神（300204）披露完成工商变更登记公告，9月30日股价上涨3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671783361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671783361?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:37","pubTimestamp":1790779031,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，舒泰神报收于20.44元，较前一交易日上涨3.55%，最新总市值为110.65亿元。该股当日开盘19.74元，最高20.98元，最低19.71元，成交额达4.34亿元，换手率为4.66%。近日，舒泰神（北京）生物制药股份有限公司披露《关于完成工商变更登记的公告》。公告显示，2026年09月10日，公司召开2026年第二次临时股东会，审议通过了《公司章程修正案》。公司已完成工商变更登记手续，并取得北京经济技术开发区市场监督管理局换发的《企业法人营业执照》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000038324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300204","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670407722","title":"舒泰神（300204）9月24日主力资金净卖出2370.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670407722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670407722?lang=zh_cn&edition=full","pubTime":"2026-09-28 09:25","pubTimestamp":1790558707,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，舒泰神报收于20.02元，下跌4.12%，换手率3.18%，成交量14.43万手，成交额2.95亿元。近5日资金流向一览见下表：舒泰神融资融券信息显示，融资方面，当日融资买入1953.14万元，融资偿还2105.77万元，融资净偿还152.63万元。舒泰神主营业务：自主知识产权创新药物,特别是生物药物的研发、生产和营销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800002954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0239","300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159259","title":"9月21日舒泰神涨5.24%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159259","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159259?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980372,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日舒泰神涨5.24%，收盘报20.89元，换手率5.38%，成交量24.41万手，成交额5.08亿元。重仓舒泰神的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","159760","300204","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668294427","title":"舒泰神最新公告：子公司注射用波米泰酶α新增适应症临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2668294427","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668294427?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:35","pubTimestamp":1789724109,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，公司子公司贝捷泰收到国家药监局《受理通知书》，同意受理注射用波米泰酶α新增适应症治疗大手术出血的临床试验申请。该药品为国家1类治疗用生物制品，此前已获批用于伴或不伴抑制物的血友病A或B患者出血按需治疗，并于2026年6月取得药品注册证书。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800027259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300204","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667687024","title":"股市必读：舒泰神新发布《关于部分募集资金专户销户完成的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667687024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667687024?lang=zh_cn&edition=full","pubTime":"2026-09-14 00:59","pubTimestamp":1789318749,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，舒泰神报收于19.68元，下跌2.19%，换手率2.39%，成交量10.85万手，成交额2.13亿元。公司公告汇总关于部分募集资金专户销户完成的公告舒泰神（北京）生物制药股份有限公司于2026年7月10日完成向特定对象发行人民币普通股63,571,790股，募集资金总额为1,252,999,980.90元，扣除发行费用后实际募集资金净额为1,227,982,460.70元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666289575","title":"舒泰神（300204）披露2026年第二次临时股东会决议公告，9月11日股价下跌2.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666289575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666289575?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:26","pubTimestamp":1789118800,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，舒泰神报收于19.68元，较前一交易日下跌2.19%，最新总市值为106.54亿元。该股当日开盘20.0元，最高20.05元，最低19.42元，成交额达2.13亿元，换手率为2.39%。近日，舒泰神（北京）生物制药股份有限公司发布2026年第二次临时股东会决议公告。公告显示，公司于2026年9月10日召开2026年第二次临时股东会，会议采用现场与网络投票相结合方式召开，出席会议股东及代理人共422人，代表股份198,721,298股，占公司有表决权股份总数的36.7089%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100037625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300204","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131976","title":"舒泰神：公司将于2026年9月10日召开2026年第二次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131976","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665131976?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:03","pubTimestamp":1788775380,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日，舒泰神发布公告称，公司将于2026年9月10日召开2026年第二次临时股东会。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqzhfq9518028.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqzhfq9518028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0239","300204","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386370","title":"舒泰神：注射用波米泰酶α正积极推进全国挂网采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664386370?lang=zh_cn&edition=full","pubTime":"2026-09-04 11:37","pubTimestamp":1788493047,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神(300204)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，公司定增已完成资金充足，加强推进已三期临床试验之时，也希望加大推进博佳凝注射液的挂网及医院力度。请问一下除了江苏省挂网，还有那里挂网的吗？谢谢！舒泰神回复：您好！公司产品注射用波米泰酶α（博佳凝）于2026年6月获得药品注册证书后，公司正同步积极推进该产品在全国各地的挂网采购、国家医保谈判及医院准入工作，以期尽早造福广大血友病患者。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400016751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662143750","title":"舒泰神（300204）2026年中报简析：净利润同比下降49.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662143750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662143750?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:28","pubTimestamp":1787696923,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期舒泰神发布2026年中报。根据财报显示，舒泰神净利润同比下降49.25%。截至本报告期末，公司营业总收入9289.88万元，同比下降26.03%，归母净利润-3676.75万元，同比下降49.25%。按单季度数据看，第二季度营业总收入4600.11万元，同比下降26.26%，第二季度归母净利润-2833.57万元，同比下降27.06%。本文数据来源于舒泰神2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600010200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662280738","title":"舒泰神(300204)6月30日股东户数6.4万户，较上期减少22.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662280738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662280738?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:52","pubTimestamp":1787651523,"startTime":"0","endTime":"0","summary":"证券之星消息，近日舒泰神披露，截至2026年6月30日公司股东户数为6.4万户，较3月31日减少1.86万户，减幅为22.55%。在化学制药行业个股中，舒泰神股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年3月31日至2026年6月30日，舒泰神区间跌幅为20.81%，在此期间股东户数减少1.86万户，减幅为22.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500037602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0046","300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203300","title":"图解舒泰神中报：第二季度单季净利润同比下降27.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203300","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662203300?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:03","pubTimestamp":1787594581,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神2026年中报显示，上半年度公司主营收入9289.88万元，同比下降26.03%；归母净利润-3676.75万元，同比下降49.25%；扣非净利润-3785.56万元，同比下降36.58%；其中2026年第二季度，公司单季度主营收入4600.11万元，同比下降26.26%；单季度归母净利润-2833.57万元，同比下降27.06%；单季度扣非净利润-2879.26万元，同比下降18.29%；负债率39.29%，投资收益19.12万元，财务费用718.33万元，毛利率74.05%。财报数据概要请见下图:本文数据来源于舒泰神2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661210692","title":"8月24日舒泰神跌5.32%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661210692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661210692?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:39","pubTimestamp":1787560793,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日舒泰神跌5.32%，收盘报21.0元，换手率4.63%，成交量21.02万手，成交额4.5亿元。重仓舒泰神的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0239","BK0028","BK0046","300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661126527","title":"8月21日舒泰神跌7.89%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661126527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661126527?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:45","pubTimestamp":1787301952,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日舒泰神跌7.89%，收盘报22.18元，换手率8.12%，成交量36.83万手，成交额8.21亿元。重仓舒泰神的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300204","BK0046","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660446012","title":"8月19日舒泰神跌5.49%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660446012","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660446012?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:06","pubTimestamp":1787130378,"startTime":"0","endTime":"0","summary":"证券之星消息，8月19日舒泰神跌5.49%，收盘报22.91元，换手率5.8%，成交量26.3万手，成交额6.15亿元。重仓舒泰神的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900029086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0028","159760","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660433485","title":"舒泰神（300204）披露子公司完成工商变更登记公告，8月17日股价下跌0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660433485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660433485?lang=zh_cn&edition=full","pubTime":"2026-08-17 22:05","pubTimestamp":1786975512,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，舒泰神报收于24.92元，较前一交易日下跌0.44%，最新总市值为134.9亿元。该股当日开盘24.88元，最高25.26元，最低24.19元，成交额达7.18亿元，换手率为6.38%。舒泰神（北京）生物制药股份有限公司于近日收到子公司江苏贝捷泰生物科技有限公司的通知，因生产经营管理需要，贝捷泰对公司经营范围进行了变更，并已完成工商变更登记，取得无锡市惠山区数据局换发的《营业执照》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700034815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300204","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659147804","title":"舒泰神（300204）披露公司董事辞职公告，8月14日股价下跌3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659147804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659147804?lang=zh_cn&edition=full","pubTime":"2026-08-14 22:03","pubTimestamp":1786716227,"startTime":"0","endTime":"0","summary":"公告显示，公司董事会于2026年8月13日收到董事汪晓燕女士的书面辞职报告，其因个人职业规划及精力安排原因，申请辞去公司董事职务，辞职生效后不再担任公司任何职务。汪晓燕女士原定任期至2027年8月第六届董事会届满之日止。其辞职不会导致公司董事会成员低于法定最低人数，自公司收到辞职报告之日起生效。截至公告日，汪晓燕女士未持有公司股份，无应履行未履行承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400039516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300204","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659132238","title":"8月13日舒泰神涨7.90%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659132238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659132238?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:38","pubTimestamp":1786610331,"startTime":"0","endTime":"0","summary":"证券之星消息，8月13日舒泰神涨7.90%，收盘报25.82元，换手率14.92%，成交量67.7万手，成交额17.29亿元。重仓舒泰神的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300026905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","159760","BK0046","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658634089","title":"舒泰神：注射用波米泰酶α已获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2658634089","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658634089?lang=zh_cn&edition=full","pubTime":"2026-08-11 09:15","pubTimestamp":1786410926,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神08月10日在投资者关系平台上答复投资者关心的问题。注射用波米泰酶α（博佳凝）于2024年6月获得药品注册证书后，公司已按照既定计划有序组织生产工作，并已完成药品生产许可换发。目前，公司正同步积极推进该产品的挂网采购、国家医保谈判及医院准入工作，以期尽早造福广大血友病患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100007309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0046","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658632619","title":"舒泰神：积极推进博佳凝挂网采购、医保谈判及医院准入","url":"https://stock-news.laohu8.com/highlight/detail?id=2658632619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658632619?lang=zh_cn&edition=full","pubTime":"2026-08-11 09:15","pubTimestamp":1786410926,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神(300204)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，公司全球首创治疗血友病患者的（博佳凝）注射液已成功上市，造福血友病AB患者，请问一下有加入医院等体系吗？可有积极向海外销售与订单？为提高公司业绩而努力。谢谢！舒泰神回复：您好！公司正在积极推进注射用波米泰酶α（博佳凝）的挂网采购、国家医保谈判及医院准入工作，以期尽早造福广大血友病患者。感谢您对公司的关注，谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100007308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791904167828,"stockEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.0422},{"period":"3month","weight":-0.1121},{"period":"6month","weight":-0.3668},{"period":"1year","weight":-0.382},{"period":"ytd","weight":-0.2493}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0234},{"period":"3month","weight":-0.0428},{"period":"6month","weight":-0.0571},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0432}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"舒泰神(北京)生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"64017人(较上一季度减少22.55%)","perCapita":"7086股","listingDate":"2011-04-15","address":"北京市大兴区北京经济技术开发区经海二路36号","registeredCapital":"54134万元","survey":" 舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是苏肽生（注射用鼠神经生长因子）、特色品种舒泰清（复方聚乙二醇电解质散（IV））及其系列产品。","listedPrice":52.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"舒泰神,300204,舒泰神股票,舒泰神股票老虎,舒泰神股票老虎国际,舒泰神行情,舒泰神股票行情,舒泰神股价,舒泰神股市,舒泰神股票价格,舒泰神股票交易,舒泰神股票购买,舒泰神股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}